Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2026
    • The 2026 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2026 Leadership
    • 2025 Winners
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • Subscribe

Medtronic CoreValve® System Gains CE Mark for New Direct Aortic Approach to Transcatheter Aortic Valve Implantation

November 8, 2011 By AxoGen, Inc.

MINNEAPOLIS–(BUSINESS WIRE)–Medtronic, Inc. (NYSE:
MDT) today announced it has received CE (Conformité Européenne) Mark for the
Medtronic CoreValve® System to be delivered using direct aortic access. The
Medtronic CoreValve System is now the only transcatheter aortic valve
implantation (TAVI) system approved for direct aortic and subclavian
implantation. The Medtronic CoreValve System is currently limited to
investigational use in the United
States.

“For patients at high risk for surgery, transcatheter aortic
valve implantation has become an established alternative for aortic valve
replacement, yet we have found that some patients are considered unsuitable
because of small vessel size,” said Giuseppe Bruschi, M.D., cardiac surgeon at
A De Gasperis Cardiology & Cardiac Surgery Department, Niguarda Ca Granda
Hospital, Milan, Italy. “For these patients, the direct aortic approach
provides a minimally-invasive surgical option.”

This new approach will provide severe aortic stenosis
patients with a viable treatment alternative to the transfemoral (in the upper
leg), transapical (through the wall of the heart), and subclavian artery
(beneath the collar bone) approaches used by TAVI practitioners. In the
procedure, physicians replace the diseased valve through a minimally invasive
incision without stopping the heart or penetrating the hearts ventricular
wall. Early evaluations have shown the direct aortic approach demonstrates high
procedural success rates and high overall survival rates that are similar to
those from transfemoral and subclavian approaches. The new approach also may
allow for easier manipulation and positioning of the valve due to the short
distance from access site to implantation site.

“The direct aortic approach gives heart teams a new,
minimally-invasive option as they seek to customize care for their patients,”
said John Liddicoat, senior vice president of Medtronic and president of the
Medtronic Structural Heart Business. “The CoreValve System is now available in
three sizes (26mm, 29mm and 31mm) via three access routes, all based on the
Systems original self-expanding platform that received CE Mark in 2007.”

The CoreValve System is designed to replace diseased aortic
valves without open-heart surgery. Worldwide, approximately 300,000 people have
been diagnosed with this condition, and approximately one-third of these
patients are deemed at too high a risk for open-heart surgery1. Since 2007, the
Medtronic CoreValve System has been implanted in more than 20,000 people in
more than 50 countries.

About Medtronic

Medtronic, Inc. (www.medtronic.com), headquartered in Minneapolis, is the global leader in medical
technology – alleviating pain, restoring health, and extending life for
millions of people around the world.

Any forward-looking statements are subject to risks and
uncertainties such as those described in Medtronics periodic reports on file
with the Securities and Exchange Commission. Actual results may differ
materially from anticipated results.

1 Decision-making in elderly patients with severe aortic
stenosis: why are so many denied surgery? Bernard Iung et al. Eur Heart
J (December 2005) 26(24): 2714-2720.

Related Articles Read More >

An illustration showing the Autus size-adjustable heart valve being expanded years after implantation with a minimally invasive balloon catheter.
The first-of-its-kind Autus pediatric heart valve is designed for expansion and durability
The MIT researcher's implant, LUCID.
MIT researchers design implantable ultrasound-powered drug delivery device to minimize tumor recurrence
An image of the Teleflex Freesolve RMS resorbable magnesium scaffold.
Teleflex Interventional leader sees resorbables as ‘the next frontier’ of PCI
Feminai's breast sensor patch
AdvaMed and MedTech Innovator name 2026 prize winners and finalists
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2026 Arrowfly, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2026
    • The 2026 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2026 Leadership
    • 2025 Winners
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • Subscribe